Changes in epidermal growth factor receptor expression in human bladder cancer cell lines following interferon-α treatment

Journal of Urology

Volumn 172, Issue 2, 2004, Pages 733-738

  Qu, Xian Jun ^a   Yang, Jia Lin ^b   Russell, Pamela J ^b   Goldstein, David ^b,c  

^a SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Bladder; Bladder neoplasms; Cell line; Epidermal growth factor; Interferon alpha

Indexed keywords

ALPHA INTERFERON; CRYSTAL VIOLET; EPIDERMAL GROWTH FACTOR RECEPTOR; RECOMBINANT ALPHA2A INTERFERON;

ANTIGEN BINDING; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CANCER; CANCER INHIBITION; CELL PROLIFERATION; CLONOGENESIS; COLORIMETRY; CONTROLLED STUDY; DRUG MECHANISM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

EID: 3142615373     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000130751.83953.55     Document Type: Article

References (17)

1. Malmstrom, P. U.: A randomized comparative dose-ranging study of interferon-alpha and mitomycin-C as an internal control in primary or recurrent superficial transitional cell carcinoma of the bladder. BJU Int, 89: 681, 2002
2. O'Donnell, M. A., Krohn, J. and DeWolf, W. C.: Salvage intravesical therapy with interferon-α2B plus low dose bacillus Calmette-Guerin is effective in patients with superficial bladder cancer in whom bacillus Calmette-Guerin alone previously failed. J Urol, 166: 1300, 2001
3. Nishi, H., Neta, G., Nishi, K. H., Akers, L. M., Rikiyama, T., Proctor, K. N. et al: Analysis of the epidermal growth factor receptor promoter: the effect of nuclear factor-kappaB. Int J Mol Med, 11: 49, 2003
4. Caraglia, M., Tagliaferri, P., Correale, P., Genua, G., Pinto, A., Del Vecchio, S. et al: Cytosine arabinoside increases the binding of 125I-labelled epidermal growth factor and 125I-transferrin and enhances the in vitro targeting of human tumour cells with anti-(growth factor receptor) mAb. Cancer Immunol Immunother, 37: 150, 1993
5. Caraglia, M., Pinto, A., Correale, P., Zagonel, V., Genua, G., Leardi, S. et al: 5-Aza-2′-deoxycytidine induces growth inhibition and upregulation of epidermal growth factor receptor on human epithelial cancer cells. Ann Oncol, 5: 269, 1994
6. Heise, H., Depenbrock, H., Rastetter, J. W. and Hanauske, A. R.: Characterization and mutual ligand-induced modulation of epidermal growth factor and interferon-alpha receptors on renal carcinoma cells in vitro. Anticancer Drugs, 6: 686, 1995
7. Budillon, A., Tagliaferri, P., Caraglia, M., Torrisi, M. R., Normanno, N., Iacobelli, S. et al: Upregulation of epidermal growth factor receptor induced by alpha-interferon in human epidermoid cancer cells. Cancer Res, 51: 1294, 1991
8. Mueller, H., Loop, P., Liu, R., Wosikowski, K., Kueng, W. and Eppenberger, U.: Differential signal transduction of epidermal-growth-factor receptors in hormone-dependent and hormone-independent human breast cancer cells. Eur J Biochem, 221: 631, 1994
9. Eisenkraft, B. L., Nanus, D. M., Albino, A. P. and Pfeffer, L. M.: Alpha-interferon down-regulates epidermal growth factor receptors on renal carcinoma cells: relation to cellular responsiveness to the antiproliferative action of alpha-interferon. Cancer Res, 51: 5881, 1991
10. Fish, E. N., Ghislain, J., Trogadis, J. and Stevens, J. K.: Inhibitory effects of alpha-interferon on epidermal growth factor-mediated receptor-dependent events. Cancer Res, 53: 5148, 1993
11. Rubinstein, Y. R., Proctor, K. N., Bergel, M., Murphy, B. and Johnson, A. C.: Interferon regulatory factor-1 is a major regulator of epidermal growth factor receptor gene expression. FEBS Lett, 431: 268, 1998
12. Gamero, A. M. and Lamer, A. C.: Vanadate facilitates interferon alpha-mediated apoptosis that is dependent on the Jak/Stat pathway. J Biol Chem, 276: 13547, 2001
13. Ueno, H., Sasaki, K., Miyagawa, K., Honda, H., Mitani, K., Yazaki, Y. et al: Antisense repression of proto-oncogene c-Cbl enhances activation of the JAK-STAT pathway but not the ras pathway in epidermal growth factor signaling. J Biol Chem, 272: 8739, 1997
14. Cheng, J., Huang, H., Zhang, Z. T., Shapiro, E., Pellicer, A., Sun, T. T. et al: Overexpression of epidermal growth factor receptor in urothelium elicits urothelial hyperplasia and promotes bladder tumor growth. Cancer Res, 62: 4157, 2002
15. Modjtahedi, H., Moscatello, D. K., Box, G., Green, M., Shotton, C., Lamb, D. J. et al: Targeting of cells expressing wild-type EGFR and type-III mutant EGFR (EGFRvIII) by anti-EGFR MAb ICR62: a two-pronged attack for tumour therapy. Int J Cancer, 105: 273, 2003
16. Perrotte, P., Matsumoto, T., Inoue, K., Kuniyasu, H., Eve, B. Y., Hicklin, D. J. et al: Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice. Clin Cancer Res, 5: 257, 1999
17. Dinney, C. P., Parker, C., Dong, Z., Fan, D., Eve, B. Y., Bucana, C. et al: Therapy of human transitional cell carcinoma of the bladder by oral administration of the epidermal growth factor receptor protein tyrosine kinase inhibitor 4,5-dianilinophthalimide. Clin Cancer Res, 3: 161, 1997